LUNG CANCER SCREENING

Transcription

1 Moving Forward with Improved Lung Cancer Detection What s Stake Now? LUNG CANCER SCREENING & CONTINUUM OFatCARE ACI S 5TH ANNUAL ACHIEVING EXCELLENCE IN LUNG CANCER SCREENING & CONTINUUM OF CARE Developing, Implementing and Advancing Lung Cancer Screening Programs and Treatments for Competitive Advantage, Greater Access to Care and Improved Outcomes OCTOBER 4-6, 2016 MINEOLA, NEW YORK Featuring a Tour of the Winthrop-University Hospital: Founded in 1896, Winthrop-University Hospital is Long Island s first voluntary and second largest hospital. The university-affiliated medical center offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. Winthrop boasts several specialized Centers that are dedicated to Cancer Care, Digestive Disorders, Family Care including Women s and Children s Health Services, Lung Care and Neurosciences. Winthrop s Lung Cancer Screening Program was started in 2012 as part of our multidisciplinary Lung Cancer Program. The program is certified by both Lung Cancer Alliance and American College of Radiology. Key topics to be covered include; how to: Identifying Patients at high risk for the development of lung cancer Understanding some of the challenges for implementation of a Low Dose CT screening program, and receive tools to address such challenges Review the guidelines regarding patient selection for Low Dose CT screening Lung Cancer Screening and Smoking Cessation Developing clinical protocols for promoting smoking cessation in Lung Cancer Screening settings Best practices for controlling screening quality, radiation dose, and diagnostic procedures How to deploy lung cancer screening responsibly and equitably Administrative aspects of operating a Lung Cancer Screening program, and multi-disciplinary view points from the non-physician perspective Developing a comprehensive Lung Cancer Screening program as a center of excellence Essential elements needed to initiate and maintain a screening program How to approach on building a Lung Cancer Screening program from the ground up; benefits behind service line development Implementing strategies to appropriately screen and ensure patient follow up Exploring the latest advances in CT imaging and biomedical research Conference Co-Sponsor: Other Sponsors Include: Analysis and reporting mechanisms for results in existing Lung Cancer Screening Programs and Centers Discussing how much would a screening program would cost, if implemented on a national scale Media Partners Include:

2 Content & Theme: LUNG CANCER SCREENING & CONTINUUM OF CARE Routine CT lung cancer screening of high-risk individuals would save thousands of lives per year for less than a dollar a month per patient if it were implemented throughout the U.S. -- and would be even cheaper than breast screening. Small dosage CT screening for lung cancer carried out safely, proficiently and rightfully has become a popular procedure for those diagnosed with Lung Cancer. Drawing knowledge from other screening histories, and from the recent support of the effectiveness of CT screening in a high risk population, it is clear that achieving this goal will require a well-informed public and the commitment of medical professionals to institute best practices. Advances in imaging and biomedical research will continue to evolve rapidly. The breach of CT screening into the healthcare system presents a unique opportunity to develop a coexisting mechanism for collecting data and specimens to accelerate that research and for introducing refinements into the screening process as imaging and biomedical advances occur and is validated. Given the increasing number of hospitals who study lung cancer, this conference has been developed to provide a forum to all physicians and educators. This multidisciplinary meeting will promote interaction between Medical Oncologists, Radiation Oncologists and Principle Investigators to achieve the best possible outcome for thoracic cancer patients. Invited Speakers Include: Jeff Schneider Associate Professor of Medicine Frederic W. Grannis Jr. MD, Clinical Professor of Thoracic Surgery City of Hope National Medical Center Les Ciancibello Radiology Supervisor University Hospitals Seidman Cancer Center Laurence Spier MD April Plank Co-Director, DNP Stony Brook Cancer Center HSC Jonathon Haas MD Sobeida Santana-Joseph Manager of Oncology Services The Valley Hospital Susan Mock RN, BSN, Clinical Research Coordinator The Valley Hospital Claudia Henshke PhD, MD, Director, Lung Screening Program The Mount Sinai Health System Dina Hernandez Director of Non-Breast Imaging Accreditation American College of Radiology Daniel L Miller MD, Chief, General Thoracic Surgery WellStar Health System/Mayo Clinic Care Network Clinical Professor of Surgery Medical College of Georgia/Georgia Regents University Program Director,General Surgery Residency Program WellStar Kennestone Regional Medical Center Michael Reiter DO, Assistant Professor of Clinical Radiology, Co-Director of The Center for Lung Cancer Screening and Prevention Stony Brook Medicine Corinne Liu Attending Physician, Assistant Professor of Radiology Robert Winn MD, Director UI Cancer Center Associate Vice President for Community Based Practice University of Illinois Hospital & Health Sciences System Karen Alisa Braithwaite RN, MSN, OCN Who Should Attend: Senior-level executives representing Hospitals, Health Systems, Physician Clinics and Hospital Management Groups: Medical Oncologists Family Practice Physicians Radiation Oncologists Physical Therapists Thoracic, Surgical Oncologists Respiratory Therapists Pulmonologists Physician Assistants Internal Medicine Physicians CT Scanning Companies Nurse Navigators Oncology Nurse Navigators

3 Pre-Conference Interactive Workshop October 4, 2016 You are invited to attend this pre-conference, interactive workshop to enhance your conference experience and expertise in Lung Cancer Screening & Continuum of Care. Please note, due to the Interactive nature of the workshop, space is limited and RSVP is strongly encouraged. 2:30 PM 3:00 PM 5:00 PM WORKSHOP REGISTRATION LUNG CANCER SCREENING: EVOLVING WITH EVIDENCE AND EXPERIENCE Jeff Schneider, Associate Professor of Medicine Dr. Schneider is a medical oncologist and Associate Professor of Clinical Medicine at the SUNY Health Sciences Center at Stony Brook, Winthrop Hospital Campus where he leads the thoracic oncology program. Since December 2012, Dr. Schneider and colleagues at Winthrop have piloted a unique model of lung cancer screening designed, in part, to assess insurance reimbursement in a climate of uncertainty. CLOSE OF PRE-CONFERENCE WORKSHOP Conference Day One October 5, :00 AM 8:45 AM 9:00 AM 9:30 AM 10:00 AM REGISTRATION & CONTINENTAL BREAKFAST CHAIRPERSON S WELCOME & OPENING ADDRESS Jeff Schneider, Associate Professor of Medicine CONFERENCE KEYNOTE: CASE PRESENTATIONS IN LUNG CANCER SCREENING Jeff Schneider, Associate Professor of Medicine THORACIC SURGICAL IMPLICATIONS Implementation of population screening of high risk individuals with low dose, non-contrast computerized tomography will predictably result in early detection of thousands of small, early-stage lung cancer. In order to meet this challenge, U.S. thoracic surgeons must learn and apply lung cancer screening diagnostic algorithms in order to avoid either delay in diagnosis or unnecessary surgery. A major challenge during the next decade will be development of treatment plans for very small neoplasms and in-situ and microinvasive adenocarcinomas. Key issues to be covered include, how to: Use IELCAP and NCCN guidelines to decide which Predict prognosis for long-term survival following nodules found be screening should be surgically surgical resection of screen-detected lung cancers resected and determine whether post-operative adjuvant Decide when limited surgical resection and/or therapy is indicated. minimally invasive methods are safe and appropriate in the treatment of small, early-stage lung cancers Frederic W. Grannis Jr., MD, Clinical Professor of Thoracic Surgery City of Hope National Medical Center Frederic W. Grannis Jr. M.D. is Clinical Professor of Thoracic Surgery at City of Hope National Medical Center in Duarte, California. Dr. Grannis has spent most of his adult life treating diseases caused by tobacco products, including lung cancer. He has served as a principal investigator in the IELCAP consortium, a panel member of the National Comprehensive Cancer Network Non-small Cell Lung Cancer Guideline Committee and the Scientific Advisory Committee of the Tobacco Related Disease Projects at the University of California. His career work is based upon the premise that reduction of lung cancer morbidity and mortality can be achieved by a tri-partite combination of tobacco control policy reform, smoking cessation interventions and screening of tobacco-caused disease in high-risk individuals. MORNING REFRESHMENT BREAK & EXHIBITS

4 10:30 AM 11:15 AM 12:00 PM 1:00 PM 1:30 PM IMPLEMENTATION OF A VIABLE LUNG CANCER SCREENING PROGRAM Many aspects are involved with starting a low-dose lung cancer screening program. This course will discuss the processes, challenges and lessons learned during the implementation and opening of our program, which has been in place for two years. Attendees will learn how to: Understand the key elements required to design Develop an interdisciplinary workflow with key a successful lung screening program. contributors in the program. Explain to administrators, physicians, referrers Maintain a successful lung screening program that and technologists the benefits and challenges of benefits the hospital or clinic, as well as the beginning such a program. community and patients it serves. Les Ciancibello, Radiology Supervisor University Hospitals Seidman Cancer Center Les Ciancibello is the radiology supervisor for the Seidman Cancer Center in Cleveland, Ohio. He oversees the day-to-day operations of the general diagnostic and computed tomography department, as well as an outpatient orthopedic imaging section and a 3-D postprocessing lab. After joining the fast-paced world of single-slice CT in 2000, the modality has become a passion of his. He loves talking about it, and he teaches CT physics at the local community college. For Les, keeping up with CT s ever-changing technology is one of the profession s biggest challenges today. MINIMALLY INVASIVE SURGERY FOR SCREEN DETECTED LUNG CANCERS Laurence Spier, MD LUNCHEON FOR DELEGATES & SPEAKERS LUNG CANCER SCREENING ELIGIBILITY GUIDELINES: SHOULD THEY BE EXPLORED? The current guidelines that direct most screening centers are the Medicare guidelines which are essentially taken from the National Lung Screening Trial. However the National Comprehensive Cancer Network (NCCN) recommends that a second high risk patient group also be screened for lung cancer. This second group lowers the age to 50 and the pack years to 20 if the patient has an additional risk factor. Risk factors include lung disease, other cancers, family history of lung cancer and various exposures. Our center, along with the assistance of The Lung Cancer Alliance, conducted a survey of screening centers across the nation in order to gather data on screening results of both groups of high risk patients. Our results indicate that the second NCCN high risk group should be considered for screening as this group had a higher incidence of lung cancer found during screening. This data will be presented. Key topics to be covered, include: Attendees will be familiar with the current guidelines Attendees will be familiar with survey results including for lung cancer screening as outlined by the United screening results of the centers that participated States Preventive Services Task Force, The National Attendees will learn creative ways to include the second Lung Screening Trial, Medicare, American Cancer high risk group as outlined by NCCN as part of their Society and National Comprehensive Cancer Network screening program April Plank, Co-Director, DNP Stony Brook Cancer Center HSC Dr. April Plank is a Nurse Practitioner at Stony Brook University Medical Center and Stony Brook Cancer Center since She began her advanced degree career in the department of Pulmonary Medicine before subspecializing in lung cancer in Together with the lung cancer team, The Center for Lung Cancer Screening and Prevention opened its doors in September of The center uses the NCCN guidelines for patients wishing to be screened for lung cancer. Dr. Plank conducts various research projects as well as a clinical practice involving screening for lung cancer and tobacco cessation counselling at Stony Brook Cancer Center. LUNG CANCER SCREENING FOR NON-SURGICAL CANDIDATES: THE ROLE OF STEREOTACTIC RADIOTHERAPY This will be a brief overview of Stereotactic Body Radiotherapy in the management of Lung cancer including the technology behind treatment and the data supporting the use of SBRT in medically inoperable NSCLC. Key topics to be covered, include: Understanding the technology of SBRT How to screen patients appropriate for SBRT in The data for this treatment the management of lung cancer Jonathon Haas, MD Dr. Jonathan Haas is the Chief of Radiation Oncology at Winthrop-University Hospital and Associate Professor of Radiation Oncology at SUNY-Stony Brook School of Medicine. Dr. Haas has been named a Castle Connolly New York Metropolitan Top Doctor as well as New York Newsday Top Doctor and was the youngest Radiation Oncologist to receive these awards. He is a regular contributing guest on WABC radio in New York and was the first Radiation Oncologist to complete Cyberknife training in the New York metropolitan area. He has published extensively on the use of CyberKnife for Lung, Prostate, Spine/CNS, and Gynecologic uses for CyberKnife. He has taught physicians in this country and abroad on clinical utilization of CyberKnife and his Department at Winthrop is the largest CyberKnife practice in the United State.

5 2:00 PM 2:45 PM 3:00 PM 4:30 PM 5:00 PM THE DEVELOPMENT OF A COMMUNITY LUNG CANCER SCREENING PROGRAM The results of the National Lung Cancer Screening Trial effectively showed that screening the correct population reduces lung cancer related mortality. Cancer programs struggle with providing their community cost-effective screening options. This presentation will focus on the development of a comprehensive community lung cancer screening program. The importance of outcome measurement will also be highlighted. Attendees will learn how to: Design a comprehensive screening program that will Collaborate with multidisciplinary team to facilitate specifically target a high risk population the patients experience Measure outcomes to document findings of lung cancer screening and associated interventions Sobeida Santana-Joseph, Manager of Oncology Services The Valley Hospital Susan Mock, RN, BSN, Clinical Research Coordinator The Valley Hospital TRANSPORTATION TO VENUE TOUR: WINTHROP-UNIVERSITY HOSPITAL Founded in 1896 by a group of local physicians and concerned citizens, Winthrop-University Hospital is Long Island s first voluntary and second largest hospital. The university-affiliated medical center offers sophisticated diagnostic and therapeutic care in virtually every specialty and subspecialty of medicine and surgery. Winthrop s new 95,000 square-foot, state-of-the-art Research and Academic Center is a five-story building which was designed specifically to foster the intersection of Winthrop s science and academic missions and encourage collaboration among researchers and clinicians. Winthrop boasts several specialized Centers that are dedicated to Cancer Care, Digestive Disorders, Family Care including Women s and Children s Health Services, Lung Care and Neurosciences. Our Cancer Care Program is the only QOPI certified program on Long Island. Winthrop s Lung Cancer Screening Program was started in 2012 as part of our multidisciplinary Lung Cancer Program. The program is certified by both Lung Cancer Alliance and American College of Radiology. The screening program is coordinated by an oncology certified registered nurse who follows each case to completion. TRANSPORTATION TO VENUE END OF DAY ONE Conference Day Two October 6, :00 AM 8:45 AM 9:00 AM 10:00 AM REGISTRATION & CONTINENTAL BREAKFAST CHAIRPERSON S WELCOME & OPENING ADDRESS THE IMPORTANCE OF THE REGIMEN OF SCREENING IN MAXIMIZING THE BENEFIT AND MINIMIZING THE HARMS In CT screening for lung cancer, the regimen of screening is critical in diagnosing lung cancer early while limiting unnecessary tests and invasive procedures. The International Early Lung Cancer Action Program (I-ELCAP) has developed a regimen based on evidence collected in the I-ELCAP cohort of more than 70,000 participants. The I-ELCAP collaboration provides a new paradigm that answers the 2002 NCI call for multiple approaches to address relevant questions about screening and the Institute of Medicine (IOM) Roundtable on Evidence-based Medicine from the National Academy of Science s call for a new clinical research paradigm that takes better advantage of data generated in the course of healthcare delivery would speed and improve the development of evidence for real-world decision making. Claudia Henshke, PhD, MD, Director, Lung Screening Program The Mount Sinai Health System A pioneer and leading expert in the field of diagnostic radiology, Dr. Henschke has more than 20 years of clinical and research experience. Since 1993, she has detected some 800 lung cancers using CT scans. In reading CT scans of the lungs and tracking lung lesions, she and her team have created a protocol that recommends additional imaging to determine growth of lung lesions and possible malignancy, which saves patients unnecessary invasive testing. Today, approximately 60 sites worldwide use the screening regimen she developed. A Professor of Radiology, Dr. Henschke also heads the International Early Lung Cancer Action Program (I-ELCAP) - an international collaborative group of lung cancer experts - and has authored more than 250 peer-reviewed publications, two books and more than 30 chapters in textbooks. MORNING REFRESHMENT BREAK & EXHIBITS Sponsored by Myriad Genetics

6 10:30 AM 11:15 AM 12:00 PM 1:00 PM THE AMERICAN COLLEGE OF RADIOLOGY ACR LUNG CANCER SCREENING RESOURCES The American College of Radiology offers a number of lung cancer screening resources that assist facilities in providing safe and effective lung cancer screening. These resources include the ACR CT accreditation and designated lung cancer screening center, ACR lung cancer screening registry, lung-rads and lung cancer screening education e-learning program. This presentation will discuss how facilities can apply for and utilize these various resources in their lung cancer screening programs, including how to: Apply for and achieve ACR CT accreditation and ACR Utilize lung-rads to standardize your lung cancer lung cancer screening center designation screening ct reporting Apply for and utilize the ACR lung cancer screening Order and Utilize the ACR lung cancer screening registry as a requirement for CMS reimbursement education CME Certified Interactive learning activity Dina Hernandez, Director of Non-Breast Imaging Accreditation American College of Radiology Dina Hernandez has been a registered radiologic technologist for over 20 years. I joined the American College of Radiology in 2006 as a program specialist for the CT/MR accreditation department and am currently the director of the non-breast imaging diagnostic modality accreditation programs. In 2014, I worked with the ACR Committee on Lung Cancer Screening on the development and implementation of the ACR Lung Cancer Screening Center designation which currently has over 1800 designated facilities. LUNG CANCER SCREENING IN A COMMUNITY-BASED HEALTH SYSTEM We started our self-pay CT scanning screening program through our multi-disciplinary clinic for lung cancer in 2008 in metro-atlanta. The WellStar Health System consists of 5 hospitals, 12 imaging centers and 4 health parks providing care in 5 countries of Northwest Atlanta for 1.4 million people. To date we have screened over 1500 patients and have detected 2.1% lung cancers; early stage disease was found in 76% of screened patients versus 32% in our non-screened patients. Only 52% of our screened patients met NLST criteria for screening. This fall we are initiating an exhaled breath test for early detection of lung cancer to complement our CT scan-based program. Topics to be covered include: A successful community-based Lung cancer CT scan Exhaled breath test for lung cancer may compliment NLST criteria may be inadequate to meet the needs or screening is possible even replace CT scanning for of all patients at risk for lung cancer early detection of lung cancer Daniel L Miller, MD Chief, General Thoracic Surgery WellStar Health System/Mayo Clinic Care Network Clinical Professor of Surgery Medical College of Georgia/Georgia Regents University Program Director,General Surgery Residency Program WellStar Kennestone Regional Medical Center LUNCHEON FOR DELEGATES AND SPEAKERS INCIDENTAL FINDINGS ON LUNG CANCER SCREENING CT As part of the American College of Radiology s (ACR) Lung Imaging Reporting and Data System (Lung-RADS), clinically significant or potentially significant findings are given a category S modifier as a means to standardize radiologist interpretation and to convey unified information to clinicians. In order to meet quality reporting requirements decreed by the Centers for Medicare and Medicaid Services (CMS), the ACR recently developed the Lung Cancer Screening Registry (LCSR) which outlines a few examples of clinically significant findings worthy of S category designation. However, there are no defined guidelines of what constitutes a clinically significant finding in Lung-RADS as opposed to the categorization of extracolonic findings as a component of the CT Colonography Reporting and Data System (C-RADS). Agreement amongst radiologists has previously been shown to be lacking with regards to many common incidental findings encountered on CT. Even for incidental findings with well delineated guidelines on further management, such as Fleischner Society s recommendations for small pulmonary nodules, there are varying degrees of conformance. Variability of radiologist interpretation of incidental findings can lead to confusion amongst health care providers and potentially increase costs due to further testing. There is a need for more structured guidelines with regards to incidental findings on lung cancer screening CT. Educational goals of this presentation include: Introduce concept of incidental findings and their Describe some of the more common incidental potential relevance findings on lung cancer screening CT Review management algorithms based on available research for frequently encountered incidentals Michael Reiter, DO, Assistant Professor of Clinical Radiology, Co-Director of The Center for Lung Cancer Screening and Prevention Stony Brook Medicine Dr. Michael Reiter, Assistant Professor of Clinical Radiology, graduated from New York College of Osteopathic Medicine, continuing on to do his Radiology Residency at the Walter Reed Army Medical Center in Washington DC. He was appointed to Stony Brook University Medical Center in 2014, he specializes in General Diagnostic Radiology, Body Imaging, and Cardiac Imaging Radiology.

7 1:45 PM 2:15 PM 3:00 PM EXTRAPULMONARY MALIGNANCIES IN LUNG CANCER SCREENING Low dose chest CT includes extrapulmonary structures of the thorax and upper abdomen, which can lead to a number of findings unrelated to depicting lung cancer. Neoplasms are the most important incidental finding as they have the potential to cause significant morbidity and mortality. Incidental extrapulmonary malignancies are presented and compared with previous studies. Attendees will learn how to: Limitations of low dose chest Ct in depicting Importance of extrapulmonary findings extrapulmonary findings Additional potential value of low dose chest CT Corinne Liu, Attending Physician, Assistant Professor of Radiology Dr. Corinne Liu is Board Certified in Diagnostic Radiology. She completed her medical degree from Stony Brook University School of Medicine. Dr. Liu s post-graduate training includes an internship in internal medicine and a residency in Diagnostic Radiology at Stony Brook University Hospital and Nassau University Medical Center where she served as Chief Resident. She then completed a fellowship in Oncologic Body Imaging at Memorial Sloan Kettering Cancer Center. She joined the Department of Radiology at in 2011 where she is an Attending Radiologist and Assistant Professor of Radiology at Stony Brook University School of Medicine. She is an integral member of Winthrop s Thoracic tumor board and is Co-Director of the Lung Cancer Screening program. INNOVATIVE MODELS OF LUNG CANCER SCREENING IN UNDERSERVED COMMUNITIES This presentation will address the issue of defining catchment areas in underserved communities. In addition, we describe our working model of engaging our community partners. Topics to be covered include how to: Develop a better understanding of the tools to Describe how to best use the data gathered in the help define a catchment area catchment areas to have an impact on the health Gain a better idea of how to engage community of our communities partners Robert Winn, MD, Director UI Cancer Center Associate Vice President for Community Based Practice University of Illinois Hospital & Health Sciences System As a specialist in pulmonary and critical care with a primary interest in lung cancer, Dr. Winn has led and served on a number of diverse committees to develop the next generation of physician-scientists. He has received numerous awards for excellence in teaching, scholarship, leadership, and diversity service. Dr. Winn received his medical degree from the University of Michigan Medical School in Ann Arbor, Michigan. Prior to arriving at the University of Illinois Hospital & Health Sciences System, Winn was an Associate Professor in the Department of Medicine, Division of Pulmonary/Critical Care Medicine at the University of Colorado Health Sciences Center, where he was also the Sr. Medical Director for the University of Colorado Multidisciplinary Pulmonary Clinic. As a specialist in Pulmonary and Critical Care, he practiced at both the University Hospital and the Veteran Affairs Medical Center in Denver, both in ambulatory medicine and the intensive care unit. NAVIGATING THROUGH THE LDCT SCREENING PROCESS: A NURSE COORDINATOR S PERSPECTIVE The presentation will cover how the coordinator of the lung cancer screening program plays a vital role in coordinating and growing the program. Utilizing a nurse coordinator adds an essential member to the multidisciplinary team of the lung cancer screening program by providing patient education, community outreach, communicating with referring providers, and guiding the patients through the medical system. Topics to be covered include how to: Describing the role of a registered nurse as the Utilizing the nurse coordinator to promote the coordinator of the screening program lung cancer screening program among primary care Optimizing screening outcomes and adherence to providers follow up Karen Alisa Braithwaite, RN, MSN, OCN Karen Alisa Braithwaite MSN, RN, OCN is the nurse coordinator for s Lung Cancer Screening Program. She obtained her Bachelor s Degree in Biological Basis of Behavior from the University of Pennsylvania in 2000, her Associate Degree in Nursing from Queensborough Community College in 2007 and her Master of Science in Nursing from the University of Phoenix in She has been an oncology certified registered nurse since Ms. Braithwaite has over 15 years of experience working in the oncology field, including working with breast, cervical and lung cancer screening patients.

8 3:45 PM 4:00 PM AFTERNOON REFRESHMENT BREAK & EXHIBITS INTERACTIVE PANEL DISCUSSION: DEVELOPING AND IMPLEMENTING COMPREHENSIVE LUNG CANCER SCREENING PROGRAMS Participate in this lively interactive exchange between all presenting faculty and conference attendees. Presenters will provide a short summary of key points from their original programs and open the floor to questions and comments from participants. Registrants are encouraged to submit questions prior to this live event. 5:00 PM CHAIRPERSON S CLOSING / CLOSE OF CONFERENCE Conference Venue: Long Island Marriott 101 James Doolittle Blvd. Uniondale, NY The Long Island Marriott showcases refined style, modern comfort, and a prime location near Garden City and Hempstead. Our hotel places the best of the area at your fingertips, from Hofstra University to the Nassau Coliseum. Make yourself at home in our well-designed rooms and suites, which feature high-speed Internet, pillow top bedding, and marble bathrooms. Helpful amenities for your Long Island visit include a heated indoor pool, a whirlpool, and a fully equipped gym. Catch the big game while you re here in Garden City with a visit to Champions, our on-site sports bar, or enjoy fresh American fare at Prime Seasons. For those hosting events in the Hempstead area, our hotel offers nearly 20,000 square feet of flexible venue space and professional planning services. Post-meeting, you and your colleagues can unwind with a game of racquetball on one of our two courts. For a hotel visit that exceeds your every expectation, book with us here at the Long Island Marriott. Active Communications International: Active Communications International, Inc. (ACI) is a leader in conference planning and production. With offices in Chicago, London, Pune, Portland, Poznan and Milwaukee, we produce world-class events focusing on areas of most relevance to our served industry sectors. We are dedicated to deliver high-quality, informative and value added strategic business conferences where audience members, speakers, and sponsors can transform their business, develop key industry contacts and walk away with new resources. Mission Statement: ACI s mission is to unite key industry influencers and leaders to build strong relationships and enable our clients to achieve operational efficiencies, maintain competitive advantage in the marketplace, and increase their profitability. Quality: ACI invites senior-level executives and key industry leaders to share their insights and real-life working experiences with our audience. Our unique conference format offers an intimate and time-efficient educational development platform where our attendees can meet one-on-one with the people that can assist them in achieving their goals. Research: ACI offers cutting-edge conferences that are developed through extensive research and development with industry experts to bring you the latest trends, forecasts, and best practices. Experience: Our team of experienced conference producers and managers know you and your business demands. ACI has the resources, knowledge, and experience to create the events you need to remain on the forefront of your industry.